The percentage of NKT-like cells with cytotoxic phenotype CD3+CD56+CD16+ was observed to be increased in patients with critical COVID-19, while the proportion of these cells expressing granzyme B was decreased in ICU patients along with a decrease in their cytotoxicity [68]. The gene discussed is FCGR3A; the disease is COVID-19.